Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin SR for mild to moderate community-acquired pneumonia in Japanese adults
NCT00360295Phase 3Completed
- Sponsor
- Pfizer
- Start
- Sep 2006
- Primary completion
- May 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of azithromycin in community acquired pneumonia (CAP), sponsored by Pfizer. Primary endpoint: Data Review Committee's Clinical Efficacy at Day 8. Started Sep 2006; status: completed.
02
Drugs
azithromycin
03
Conditions
community acquired pneumonia (CAP)
Beyond the preview
Go deeper on NCT00360295.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00360295.